Genotyping Market
According to Intent Market Research, the Genotyping Market is expected to grow from USD 11.7 billion in 2024-e at a CAGR of 15.9% to touch USD 32.8 billion by 2030. The Genotyping Market is dominated by key players such as Thermo Fisher Scientific, Illumina, Inc., Roche Diagnostics, Agilent Technologies, Bio-Rad Laboratories, Inc., Qiagen N.V., PerkinElmer, Inc., Abbott Laboratories, Danaher Corporation, GE Healthcare, Pacific Biosciences of California, Inc., Thermo Fisher Scientific, Becton, Dickinson and Company, Agilent Technologies, 10x Genomics.